Greenfield Seitz Capital Management’s Gilead Sciences GILD Stock Holding History

Greenfield Seitz Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,914	Closed	-$639K	–	112
2024 Q4	$639K	Buy	6,914 +20	+0.3%	+$1.8K	0.24%	67
2024 Q3	$578K	Sell	6,894 -1,274	-16%	-$97.2K	0.21%	75
2024 Q2	$560K	Sell	8,168 -1,849	-18%	-$123K	0.21%	74
2024 Q1	$734K	Sell	10,017 -4,675	-32%	-$359K	0.27%	68
2023 Q4	$1.19M	Buy	+14,692	New	+$1.14M	0.47%	52

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenfield Seitz Capital Management's GILD Position: Q1 2025 in Review

Greenfield Seitz Capital Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 6,914 shares — an estimated $639K sold.

Greenfield Seitz Capital Management first reported a position in GILD in Q4 2023 and held it in 5 quarters. The position peaked at $1.19M in Q4 2023. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Greenfield Seitz Capital Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Greenfield Seitz Capital Management sold 6,914 Gilead Sciences shares in Q1 2025, an estimated $639K.
Greenfield Seitz Capital Management first reported a position in Gilead Sciences in Q4 2023 and held it in 5 quarters.
Greenfield Seitz Capital Management's Gilead Sciences position peaked at $1.19M in Q4 2023.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Greenfield Seitz Capital Management's 13F filing for Q1 2025, filed 24 Nov 2025.